Methyl gallate: Selective antileishmanial activity correlates with host-cell directed effects.
暂无分享,去创建一个
C. N. Dias | L. H. Costa | A. J. Araújo | Márcia Rosa de Oliveira | K. Rodrigues | Marcos Vinícius da Silva | Thaís Amanda Lima Nunes | Julyanne Maria Saraiva de Sousa | Raiza Raianne Luz Rodrigues | José Delano Barreto Marinho Filho | Fernando Aécio de Amorim Carvalho | Klinger A. F. Rodrigues | Marcos Vinícius da Silva
[1] F. Gamarro,et al. 4-Aminoquinoline-based compounds as antileishmanial agents that inhibit the energy metabolism of Leishmania. , 2019, European journal of medicinal chemistry.
[2] A. Feliz,et al. A Review of the Microbial Production of Bioactive Natural Products and Biologics , 2019, Front. Microbiol..
[3] C. Antwi,et al. In vitro activity and mode of action of phenolic compounds on Leishmania donovani , 2019, PLoS neglected tropical diseases.
[4] S. Croft,et al. Leishmaniasis , 2018, The Lancet.
[5] M. Chaves,et al. Gallic and ellagic acids: two natural immunomodulator compounds solve infection of macrophages by Leishmania major , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.
[6] D. Steverding. The history of leishmaniasis , 2017, Parasites & Vectors.
[7] A. Maciuk,et al. Bioactive phloroglucinols from Mallotus oppositifolius. , 2015, Fitoterapia.
[8] M. Scotti,et al. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro. , 2015, European journal of medicinal chemistry.
[9] E. Andrade,et al. Leishmanicidal Activity of (+)-Phyllanthidine and the Phytochemical Profile of Margaritaria nobilis (Phyllanthaceae) , 2015, Molecules.
[10] I. Müller,et al. Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages , 2014, Front. Immunol..
[11] E. Saraiva,et al. Resveratrol Is Active against Leishmania amazonensis: In Vitro Effect of Its Association with Amphotericin B , 2014, Antimicrobial Agents and Chemotherapy.
[12] A. Kaur,et al. Antileishmanial Compounds from Moringa oleifera Lam. , 2014, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[13] W. Setzer,et al. Antileishmanial phytochemical phenolics: molecular docking to potential protein targets. , 2014, Journal of molecular graphics & modelling.
[14] S. Mohapatra. Drug resistance in leishmaniasis: Newer developments , 2014, Tropical parasitology.
[15] L. Floeter-Winter,et al. Arginase in Leishmania. , 2014, Sub-cellular biochemistry.
[16] R. Cotton,et al. Leishmania major inhibits IL‐12 in macrophages by signalling through CR3 (CD11b/CD18) and down‐regulation of ETS‐mediated transcription , 2013, Parasite immunology.
[17] Márcia R. Oliveira,et al. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro. , 2013, Experimental parasitology.
[18] R. Melo,et al. LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis. , 2013, The Journal of antimicrobial chemotherapy.
[19] M. L. Vasconcellos,et al. Morita-Baylis-Hillman adduct shows in vitro activity against Leishmania (Viannia) braziliensis associated with a reduction in IL-6 and IL-10 but independent of nitric oxide , 2012, Parasitology.
[20] N. Shakya,et al. Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam3Cys against experimental Visceral Leishmaniasis. , 2012, Experimental parasitology.
[21] M. Piuvezam,et al. Leishmanicidal effect of Spiranthera odoratíssima (Rutaceae) and its isolated alkaloid skimmianine occurs by a nitric oxide dependent mechanism , 2011, Parasitology.
[22] R. Curi,et al. Modulation of peritoneal macrophage activity by the saturation state of the fatty acid moiety of phosphatidylcholine. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[23] E. Riley,et al. IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.
[24] R. Peeling,et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? , 2007, Nature Reviews Microbiology.
[25] A. Khamesipour,et al. Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium sativum) treatment. , 2006, Journal of ethnopharmacology.
[26] A. Kiderlen,et al. Antileishmanial activity and immune modulatory effects of tannins and related compounds on Leishmania parasitised RAW 264.7 cells. , 2005, Phytochemistry.
[27] A. Celada,et al. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] C. Di Giorgio,et al. In vitro antileishmanial activity of diphyllin isolated from Haplophyllum bucharicum. , 2005, Planta medica.
[29] P. Chavrier,et al. Signaling and membrane dynamics during phagocytosis: many roads lead to the phagos(R)ome. , 2004, Current opinion in cell biology.
[30] S. Grinstein,et al. Phagocytosis by neutrophils. , 2003, Microbes and infection.
[31] D. Sacks,et al. The immunology of susceptibility and resistance to Leishmania major in mice , 2002, Nature Reviews Immunology.
[32] C. Westmoreland,et al. Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.